Comparing DaVita (NYSE:DVA) & Ceres Ventures (OTCMKTS:CEVE)

DaVita (NYSE:DVA) and Ceres Ventures (OTCMKTS:CEVE) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, risk, institutional ownership and valuation.

Volatility & Risk

DaVita has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500. Comparatively, Ceres Ventures has a beta of 2.03, indicating that its stock price is 103% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for DaVita and Ceres Ventures, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	1	4	0	0	1.80
Ceres Ventures	0	0	0	0	0.00

DaVita currently has a consensus price target of $155.25, suggesting a potential upside of 25.29%. Given DaVita’s stronger consensus rating and higher probable upside, equities research analysts clearly believe DaVita is more favorable than Ceres Ventures.

Earnings & Valuation

This table compares DaVita and Ceres Ventures”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$12.82 billion	0.69	$936.34 million	$10.17	12.18
Ceres Ventures	N/A	N/A	N/A	N/A	N/A

DaVita has higher revenue and earnings than Ceres Ventures.

Institutional & Insider Ownership

90.1% of DaVita shares are held by institutional investors. 1.5% of DaVita shares are held by insiders. Comparatively, 0.1% of Ceres Ventures shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares DaVita and Ceres Ventures’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DaVita	6.35%	369.39%	4.62%
Ceres Ventures	N/A	N/A	N/A

Summary

DaVita beats Ceres Ventures on 8 of the 9 factors compared between the two stocks.

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

About Ceres Ventures

Ceres Ventures, Inc., a development stage company, focuses on the research, development, and commercialization of clean technologies for the remediation of polluted water, soil, and air. Its technologies include BluFlow Nanoparticles, a proprietary system for formulating, producing, and deploying customizable absorbent nanoparticles to specific functionality for contaminant/chemical removal and extraction of valuable elements and compounds from water based solutions; BluFlow Advanced Ultrafiltration Technology, an automated process to recover water from waste or impure streams; and BluFlow Treatment System a water and wastewater treatment solution, which incorporates the BluFlow Nanoparticles and the BluFlow Advanced Ultrafiltration Technology to remove target elements, compounds, and pollutants, as well as purify water that may be suitable for reuse. Ceres Ventures, Inc.'s products are used in water and wastewater treatment and purification, contaminated groundwater treatment, industrial wastewater treatment, and valuable elements and compounds extraction applications. The company was formerly known as PhytoMedical Technologies, Inc. and changed its name to Ceres Ventures, Inc. in November 2011. Ceres Ventures, Inc. was founded in 2010 and is based in New York, New York.